Literature DB >> 4007926

Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.

A R Thomsen, M Volkert, O Marker.   

Abstract

The humoral immune response to lymphocytic choriomeningitis virus (LCMV) was analysed by the use of a sensitive ELISA. Our results show that LCMV carriers of the C3H strain, previously believed to be completely tolerant to the virus, do in fact produce LCMV-specific antibodies and, moreover, that a significant proportion of these antibodies belong to IgG subclasses which are considered T-cell dependent. This finding, together with the fact that T-cell deficient mice made little or no LCMV-specific antibodies, makes it reasonable to infer that C3H carriers have not only virus-primed B cells, but also virus-primed T-helper cells. However, the isotype profiles of the virus-specific antibodies detected were markedly different in carriers and in immune mice. Firstly, much greater inter-individual variation was observed in the carrier population than in the immune mice. Secondly, in immune mice IgG2a antibodies dominated the humoral response, whereas in carriers the virus-specific activity in this subclass was very low. In contrast, LCMV-specific antibodies of the IgG1 subclass were present in similar titres in immune mice and in the majority of the carriers. Evaluation of the IgG2b response revealed that most carriers had little or no LCMV-specific activity in this subclass, although a few had antibody levels comparable to those in immune mice. These findings are discussed in relation to the question of the state of immunity in LCMV carriers and its consequence for immune-complex disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007926      PMCID: PMC1453609     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  The activity of T and B lymphocytes in immunity and tolerance to the lymphocytic choriomeningitis virus in mice.

Authors:  M Volkert; K Bro-Jorgensen; O Marker; B Rubin; L Trier
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

2.  STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 6. IMMUNITY CONFERRED ON TOLERANT MICE BY IMMUNE SERUM AND BY GRAFTS OF HOMOLOGOUS LYMPHOID CELLS.

Authors:  M VOLKERT; J H LARSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  Immunological tolerance to lymphocytic choriomeningitis virus in neonatally infected virus carrier mice: evidence supporting a clonal inactivation mechanism.

Authors:  J Cihak; F Lehmann-Grube
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

4.  Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice.

Authors:  M B Oldstone; F J Dixon
Journal:  Science       Date:  1967-12-01       Impact factor: 47.728

5.  Concanavalin A-induced activation of lymphocytic choriomeningitis virus memory lymphocytes into specifically cytotoxic T cells.

Authors:  O Marker; A R Thomsen; G T Andersen
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-12

6.  Persistent LCM virus infection in the mouse. Immunity and tolerance.

Authors:  M Volkert; K Bro-Jorgensen; O Marker
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

7.  Immunological unresponsiveness of nude mice to LCM virus infection.

Authors:  P J Christoffersen; M Volkert; J Rygaard
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-12

8.  Subclass restriction of murine anti-carbohydrate antibodies.

Authors:  R M Perlmutter; D Hansburg; D E Briles; R A Nicolotti; J M Davie
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

9.  Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice.

Authors:  O Marker; M Volkert
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

10.  Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. II. Relationship of the anti-lymphocytic choriomeningitis immune response to tissue injury in chronic lymphocytic choriomeningitis disease.

Authors:  M B Oldstone; F J Dixon
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307

View more
  14 in total

1.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.

Authors:  K E Wright; M J Buchmeier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  The dual role of lymphocytic choriomeningitis virus-specific antibodies.

Authors:  A R Thomsen; O Marker; M Volkert
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

3.  Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice.

Authors:  J M Ball; M E Hardy; R L Atmar; M E Conner; M K Estes
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus.

Authors:  A R Thomsen; O Marker
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

5.  Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection.

Authors:  J R Baldridge; M J Buchmeier
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

6.  Bone marrow is a major site of long-term antibody production after acute viral infection.

Authors:  M K Slifka; M Matloubian; R Ahmed
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Production of random classes of immunoglobulins in brain tissue during persistent viral infection paralleled by secretion of interleukin-6 (IL-6) but not IL-4, IL-5, and gamma interferon.

Authors:  D Moskophidis; K Frei; J Löhler; A Fontana; R M Zinkernagel
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  The primary in vivo immune response to Mls-1 (Mtv-7 sag). Route of injection determines the immune response pattern.

Authors:  M Andersson; H Acha-Orbea
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

9.  An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.

Authors:  Mojca Skoberne; Rhonda Cardin; Alexander Lee; Ana Kazimirova; Veronica Zielinski; Danielle Garvie; Amy Lundberg; Shane Larson; Fernando J Bravo; David I Bernstein; Jessica B Flechtner; Deborah Long
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

10.  Adaptive immune defense prevents Bartonella persistence upon trans-placental transmission.

Authors:  Lena K Siewert; Christoph Dehio; Daniel D Pinschewer
Journal:  PLoS Pathog       Date:  2022-05-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.